Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease
OBJECTIVE: Certain drug classes alleviate the symptoms of Willis-Ekbom's disease, whereas others aggravate them. The pharmacological profiles of these drugs suggest that drugs that alleviate Willis-Ekbom's disease inhibit thyroid hormone activity, whereas drugs that aggravate Willis-Ekbom&...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2013-04-01
|
| Series: | Clinics |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000400469 |
| _version_ | 1818531263807488000 |
|---|---|
| author | José Carlos Pereira Jr Márcia Pradella-Hallinan Rosana Cardoso Alves |
| author_facet | José Carlos Pereira Jr Márcia Pradella-Hallinan Rosana Cardoso Alves |
| author_sort | José Carlos Pereira Jr |
| collection | DOAJ |
| description | OBJECTIVE: Certain drug classes alleviate the symptoms of Willis-Ekbom's disease, whereas others aggravate them. The pharmacological profiles of these drugs suggest that drugs that alleviate Willis-Ekbom's disease inhibit thyroid hormone activity, whereas drugs that aggravate Willis-Ekbom's disease increase thyroid hormone activity. These different effects may be secondary to the opposing actions that drugs have on the CYP4503A4 enzyme isoform. Drugs that worsen the symptoms of the Willis-Ekbom's disease inhibit the CYP4503A4 isoform, and drugs that ameliorate the symptoms induce CYP4503A4. The aim of this study is to determine whether Saint John's wort, as an inducer of the CYP4503A4 isoform, diminishes the severity of Willis-Ekbom's disease symptoms by increasing the metabolism of thyroid hormone in treated patients. METHODS: In an open-label pilot trial, we treated 21 Willis-Ekbom's disease patients with a concentrated extract of Saint John's wort at a daily dose of 300 mg over the course of three months. RESULTS: Saint John's wort reduced the severity of Willis-Ekbom's disease symptoms in 17 of the 21 patients. CONCLUSION: Results of this trial suggest that Saint John's wort may benefit some Willis-Ekbom's disease patients. However, as this trial was not placebo-controlled, the extent to which Saint John's wort is effective as a Willis-Ekbom's disease treatment will depend on future, blinded placebo-controlled studies. |
| first_indexed | 2024-12-11T17:30:11Z |
| format | Article |
| id | doaj.art-ec6379155691416d8f0bbf0a8b1823fb |
| institution | Directory Open Access Journal |
| issn | 1807-5932 1980-5322 |
| language | English |
| last_indexed | 2024-12-11T17:30:11Z |
| publishDate | 2013-04-01 |
| publisher | Elsevier España |
| record_format | Article |
| series | Clinics |
| spelling | doaj.art-ec6379155691416d8f0bbf0a8b1823fb2022-12-22T00:56:51ZengElsevier EspañaClinics1807-59321980-53222013-04-01684469474Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's diseaseJosé Carlos Pereira JrMárcia Pradella-HallinanRosana Cardoso AlvesOBJECTIVE: Certain drug classes alleviate the symptoms of Willis-Ekbom's disease, whereas others aggravate them. The pharmacological profiles of these drugs suggest that drugs that alleviate Willis-Ekbom's disease inhibit thyroid hormone activity, whereas drugs that aggravate Willis-Ekbom's disease increase thyroid hormone activity. These different effects may be secondary to the opposing actions that drugs have on the CYP4503A4 enzyme isoform. Drugs that worsen the symptoms of the Willis-Ekbom's disease inhibit the CYP4503A4 isoform, and drugs that ameliorate the symptoms induce CYP4503A4. The aim of this study is to determine whether Saint John's wort, as an inducer of the CYP4503A4 isoform, diminishes the severity of Willis-Ekbom's disease symptoms by increasing the metabolism of thyroid hormone in treated patients. METHODS: In an open-label pilot trial, we treated 21 Willis-Ekbom's disease patients with a concentrated extract of Saint John's wort at a daily dose of 300 mg over the course of three months. RESULTS: Saint John's wort reduced the severity of Willis-Ekbom's disease symptoms in 17 of the 21 patients. CONCLUSION: Results of this trial suggest that Saint John's wort may benefit some Willis-Ekbom's disease patients. However, as this trial was not placebo-controlled, the extent to which Saint John's wort is effective as a Willis-Ekbom's disease treatment will depend on future, blinded placebo-controlled studies.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000400469Willis-Ekbom's DiseaseRestless Legs Syndrome TreatmentRestless Legs SyndromeSaint John's WortThyroid HormoneCYP4503A4 |
| spellingShingle | José Carlos Pereira Jr Márcia Pradella-Hallinan Rosana Cardoso Alves Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease Clinics Willis-Ekbom's Disease Restless Legs Syndrome Treatment Restless Legs Syndrome Saint John's Wort Thyroid Hormone CYP4503A4 |
| title | Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease |
| title_full | Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease |
| title_fullStr | Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease |
| title_full_unstemmed | Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease |
| title_short | Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease |
| title_sort | saint john s wort an herbal inducer of the cytochrome p4503a4 isoform may alleviate symptoms of willis ekbom s disease |
| topic | Willis-Ekbom's Disease Restless Legs Syndrome Treatment Restless Legs Syndrome Saint John's Wort Thyroid Hormone CYP4503A4 |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000400469 |
| work_keys_str_mv | AT josecarlospereirajr saintjohnswortanherbalinducerofthecytochromep4503a4isoformmayalleviatesymptomsofwillisekbomsdisease AT marciapradellahallinan saintjohnswortanherbalinducerofthecytochromep4503a4isoformmayalleviatesymptomsofwillisekbomsdisease AT rosanacardosoalves saintjohnswortanherbalinducerofthecytochromep4503a4isoformmayalleviatesymptomsofwillisekbomsdisease |